• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血患者血浆组织因子途径抑制物截短形式水平升高。

Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.

作者信息

Shimura M, Wada H, Nakasaki T, Hiyoyama K, Mori Y, Nishikawa M, Deguchi H, Deguchi K, Gabazza E C, Shiku H

机构信息

Second Department of Internal Medicine, Mie University School of Medicine, Tsu-city, Japan.

出版信息

Am J Hematol. 1999 Feb;60(2):94-8. doi: 10.1002/(sici)1096-8652(199902)60:2<94::aid-ajh2>3.0.co;2-a.

DOI:10.1002/(sici)1096-8652(199902)60:2<94::aid-ajh2>3.0.co;2-a
PMID:9929099
Abstract

To evaluate that the relationship between the truncated form of tissue factor pathway inhibitor (TFPI) and the stage of disseminated intravascular coagulation (DIC), we measured the plasma levels of tissue factor (TF) antigen and the intact and truncated forms of TFPI antigens in 41 patients with DIC, 12 with pre-DIC, and 20 with non-DIC. The plasma TF and total TFPI antigen levels were significantly higher in patients with DIC than in non-DIC patients. Plasma levels of intact TFPI antigen in the pre-DIC groups were significantly lower than in the non-DIC and DIC groups. The truncated form of TFPI antigen levels in DIC patients were significantly increased compared with those in non-DIC and pre-DIC patients. The fact that the intact form of TFPI was decreased in pre-DIC patients compared with that in non-DIC patients, suggests that it is consumed in the pre-DIC state and that hypercoagulability occurs in pre-DIC patients. The increased level of the truncated form of TFPI in DIC patients may be attributed to proteolysis of the intact form of TFPI in these patients. The increased level of the truncated form of TFPI may be a useful index for the diagnosis of DIC.

摘要

为评估组织因子途径抑制物(TFPI)的截短形式与弥散性血管内凝血(DIC)分期之间的关系,我们检测了41例DIC患者、12例DIC前期患者和20例非DIC患者血浆中组织因子(TF)抗原水平以及TFPI抗原的完整形式和截短形式。DIC患者的血浆TF和总TFPI抗原水平显著高于非DIC患者。DIC前期组的完整TFPI抗原血浆水平显著低于非DIC组和DIC组。与非DIC和DIC前期患者相比,DIC患者的TFPI抗原截短形式水平显著升高。与非DIC患者相比,DIC前期患者中TFPI完整形式降低,这一事实表明其在DIC前期状态下被消耗,且DIC前期患者发生了高凝状态。DIC患者中TFPI截短形式水平升高可能归因于这些患者中TFPI完整形式的蛋白水解。TFPI截短形式水平升高可能是诊断DIC的一个有用指标。

相似文献

1
Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆组织因子途径抑制物截短形式水平升高。
Am J Hematol. 1999 Feb;60(2):94-8. doi: 10.1002/(sici)1096-8652(199902)60:2<94::aid-ajh2>3.0.co;2-a.
2
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平
Am J Hematol. 1996 Jul;52(3):165-70. doi: 10.1002/(SICI)1096-8652(199607)52:3<165::AID-AJH5>3.0.CO;2-R.
3
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.弥散性血管内凝血患者的血浆组织因子和组织因子途径抑制物水平
Am J Hematol. 1997 Aug;55(4):169-74. doi: 10.1002/(sici)1096-8652(199707)55:4<169::aid-ajh1>3.0.co;2-q.
4
Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆中组织因子途径抑制物激活的X因子复合物水平升高。
Am J Hematol. 2000 Nov;65(3):210-4. doi: 10.1002/1096-8652(200011)65:3<210::aid-ajh6>3.0.co;2-p.
5
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.弥散性血管内凝血临床过程中血浆组织因子途径抑制物水平的变化
Blood Coagul Fibrinolysis. 1998 Sep;9(6):491-7. doi: 10.1097/00001721-199809000-00006.
6
Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.弥散性血管内凝血中的血浆组织因子途径抑制物:其与血浆组织因子表现的比较
Thromb Res. 1995 Nov 15;80(4):339-48. doi: 10.1016/0049-3848(95)00185-t.
7
Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.针对组织因子途径抑制物-因子Xa复合物的单克隆抗体:其特性及在弥散性血管内凝血和弥散性血管内凝血前期患者血浆中的应用
Blood Coagul Fibrinolysis. 1999 Sep;10(6):309-19.
8
Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.
Blood Coagul Fibrinolysis. 2001 Jan;12(1):1-8. doi: 10.1097/00001721-200101000-00001.
9
Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.组织因子途径抑制物反应与创伤患者中组织因子诱导的弥散性血管内凝血及多器官功能障碍综合征不相关。
Crit Care Med. 2001 Feb;29(2):262-6. doi: 10.1097/00003246-200102000-00006.
10
[Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].[不同疾病患者血浆组织因子及组织因子途径抑制物的行为分析]
Rinsho Ketsueki. 1996 Sep;37(9):794-8.

引用本文的文献

1
Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.狒狒肺部脓毒症诱导的凝血与组织因子途径抑制物减少有关。
Am J Pathol. 2007 Sep;171(3):1066-77. doi: 10.2353/ajpath.2007.070104. Epub 2007 Jul 19.